Company & Sponsor Intelligence

Seattle Children's Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting1

Completed6

Countries1

Therapeutic footprint

adhdautismmigraine_headacheneuro_oncologypain_neuropathy

Indexed studies

NCT04936321Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial
migraine_headache · United StatesNA

NCT05093686RUBIES in Educational Settings
autism · United StatesNA

NCT06386224Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
pain_neuropathy · United StatesNA

NCT00393042Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
adhd · United StatesPHASE3

NCT01816074Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
adhd · United StatesPHASE4

NCT02255565Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
autism · United StatesPHASE4

NCT02340884A Pilot RCT of the PRISM Intervention for AYAs With Cancer
neuro_oncology · United StatesPHASE2

NCT02675400Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
adhd · United StatesPHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →